https://doi.org/10.1002/ijc.31627
H
Hyma Polimera
Reading Hospital(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
377
Citations
8
h-index
8
i10-index
Hyma Polimera is an academic researcher from Reading Hospital. The author has contributed to research in topics: COVID-19 and healthcare impacts & Cancer Immunotherapy and Biomarkers & COVID-19 Clinical Research Studies. The author has an h-index of 8, co-authored 62 publications.
Papers by this author
worksHigh turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts
2018 · International Journal of Cancer · 57 citations
A Case of Confirmed Ceftriaxone-induced Immune Thrombocytopenia
2019 · Cureus · 11 citations
https://doi.org/10.7759/cureus.4688
Hemophagocytic Lymphohistiocytosis induced by human granulocytic anaplasmosis: A case report and literature review into the immunopathogenesis
2022 · Human Pathology Reports · 7 citations
https://doi.org/10.1016/j.hpr.2022.300598
Higher serum PD‐L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial
2020 · Cancer · 6 citations
https://doi.org/10.1002/cncr.33149
Serum PD-L1 and outcomes in CCTG MA.31 phase 3 trial of anti-HER2 therapy in first-line HER2+ metastatic breast cancer patients (trastuzumab arm only).
2018 · Journal of Clinical Oncology · 5 citations
https://doi.org/10.1200/jco.2018.36.15_suppl.1031
A Case of Cefepime-Induced Neurotoxicity: Renal Function Missing in Action
2021 · Cureus · 4 citations
https://doi.org/10.7759/cureus.13368
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat